Medical Oncology

Hepatic Tumors

Questions discussed in this category

In a patient with recurrent fibrolamellar HCC a year after upfront resection (previously refused adjuvant therapy) with a solitary abdominal mass, would you offer neoadjuvant therapy to assess response?

Or offer resection followed by adjuvant therapy?

2 Answers available

Related Topics in Medical Oncology